Findings showed Brimochol PF significantly improved near vision compared with vehicle solution at all timepoints up to 8 hours (P .008). Topline data were announced from a phase 3 trial evaluating ...

Brimochol PF (carbachol/brimonidine tartrate fixed-dose combination) demonstrated improvements in near vision vs. vehicle at all study time points up to 8 hours (P <.008). Additionally ...

BRIO-II is a 3-arm, multicenter, randomized, double-masked, safety and efficacy study of BRIMOCHOL™ PF (carbachol/brimonidine tartrate fixed-dose combination) topical ophthalmic solution vs. carbachol ...